Elevated plasma levels of interleukin 8 in patients with acute anterior ischaemic optic neuropathy

British Journal of Ophthalmology

Volumn 88, Issue 12, 2004, Pages 1538-1540

  Goldenberg Cohen, Nitza ^a   Kramer, M ^b   Bahar, I ^b   Monselise, Y ^b   Weinberger, D ^b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ACUTE ANTERIOR ISCHEMIC OPTIC NEUROPATHY; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; IMMUNOPATHOLOGY; ISCHEMIC OPTIC NEUROPATHY; MALE; NON ARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY; PRIORITY JOURNAL; THROMBOGENESIS; THROMBOSIS;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTERIOR EYE SEGMENT; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; OPTIC NEUROPATHY, ISCHEMIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 9644263861     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2004.046524     Document Type: Article

References (32)

1. Esmon CT. Inflammation and thrombosis. J Thromb Haemost 2003;1:1343-8.
2. Tousoulis D, Davies G, Stefanadis C, et al. Inflammatory and thrombotic mechanisms in coronary atherosclerosis. Heart 2003;89:993-7.
3. Miya Y, Kanda T, Tamura J, et al. A new murine model of coronary artery thrombosis and role of interleukin-8 in the development of coronary thrombosis. Res Commun Mol Pathol Pharmacol 2000;108:108-15.
4. Hoch RC, Schraufstatter IU, Cochrane CG. In vivo, in vitro, and molecular aspects of interleukin-8 and the interleukin-8 receptors. J Lab Clin Med 1996;128:134-45.
5. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-45.
6. Kanda T, Hirao Y, Oshima S, et al. Interleukin-8 as a sensitive marker of unstable coronary artery disease. Am J Cardiol 1996;77:304-7.
7. Kato K, Matsubara T, Iida K, et al. Elevated levels of pro-inflammatory cytokines in coronary artery thrombi. Int J Cardiol 1999;70:267-73.
8. Foulds WS, Chisholm IA, Stewart JB, et al. The optic neuropathy of pernicious anemia. Arch Ophthalmol 1969b;82:427-32.
9. Hayreh SS. Blood supply of the optic nerve head and its role in optic atrophy, glaucoma, an oedema of the optic disc. Br J Ophthalmol 1969;53:721-48.
10. McLeod D, Marshall J, Kohner EM. Role of axoplasmic transport in the pathophysiology of ischaemic disc swelling. Br J Ophthalmol 1980;64:247-61.
11. Hayreh SS. Posterior ciliary artery circulation in health and disease: the Weisenfeld lecture. Invest Ophthalmol Vis Sci 2004;45:749-57, 748.
12. Newman NJ, Scherer R, Langenberg P, et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 2002;134:317-28.
13. Miller NR, Newman NJ, eds. Walsh & Hoyt's clinical neuro-ophthalmology, the essentials, 5th ed. Baltimore: Williams & Wilkins, 1999.
14. Barron KD, Dentinger MP, Krohel G, et al. Qualitative and quantitative ultrastructural observations on retinal ganglion cell layer of rat after intraorbital optic nerve crush. J Neurocytol 1986;15:345-62.
15. Berkelaar M, Clarke DB, Wang YC, et al. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci 1994;14:4368-74.
16. Yoshida K, Behrens A, Le-Niculescu H, et al. Amino-terminal phosphorylation of c-Jun regulates apoptosis in the retinal ganglion cells by optic nerve transection. Invest Ophthalmol Vis Sci 2002;43:1631-5.
17. Wakefield TW, Greenfield U, Rolfe MW, et al. Inflammatory and procoagulant mediator interactions in an experimental baboon model of venous thrombosis. Thromb Haemost 1993;69:164-72.
18. Monreal M, Fernandez-Llamazares J, Perandreu J, et al. Occult cancer in patients with venous thromboembolism: which patients, which cancers. Thromb Haemost 1997;78:1316-18.
19. de Maistre E, Regnault V, Lecompte T, et al. Antibodies to interleukin-8 and paraneoplastic catastrophic recurrent thromboses. Am J Med 2001;111:580-1.
20. Baggiolini M, Loetscher P, Moser B. Interleukin-8 and the chemokine family. Int J Immunopharmacol 1995;17:103-8.
21. Mukaida N. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 2000;72:391-8.
22. Tarlawe MH, Kannan KB, Itagaki K, et al. Inflammatory chemoreceptor cross-talk suppresses leukotriene B4 receptor 1-mediated neutrophil calcium mobilization and chemotaxis after trauma. J Immunol 2003;171:2066-73.
23. Harada A, Sekido N, Akahoshi T, et al. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 1994;56:559-64.
24. Maury CP, Teppo AM. Circulating tumour necrosis factor-alpha (cachectin) in myocardial infarction. J Intern Med 1989;225:333-6.
25. Guillen I, Blanes M, Gomez-Lechon MJ, et al. Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6. Am J Physiol 1995;269:R229-35.
26. Entman ML, Michael L, Rossen RD, et al. Inflammation in the course of early myocardial ischemia. Faseb J 1991;5:2529-37.
27. Matsumoto T, Ikeda K, Mukaida N, et al. Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8. Lab Invest 1997;77:119-25.
28. Hirano T, Yasukawa K, Harada H, et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986;324:73-6.
29. Kohase M, May LT, Tamm I, et al. A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1. Mol Cell Biol 1987;7:273-80.
30. Horii Y, Muraguchi A, Suematsu S, et al. Regulation of BSF-2/IL-6 production by human mononuclear cells. Macrophage-dependent synthesis of BSF-2/IL-6 by T cells. J Immunol 1988;141:1529-35.
31. Wang JM, Sica A, Peri G, et al. Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. Arterioscler Thromb 1991;11:1166-74.
32. Romuk E, Skrzep-Poloczek B, et al. Selectin-P and interleukin-8 plasma levels in coronary heart disease patients. Eur J Clin Invest 2002;32:657-61.